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Abstract
A growing body of evidence indicates that P2X receptors (P2XRs), a family of ligand-gated cation
channels activated by extracellular ATP, play an important role in pain signaling. In contrast to the
role of the P2X3R subtype that has been extensively studied, the precise roles of others among the
seven P2XR subtypes (P2X1R-P2X7R) remain to be determined because of a lack of sufficiently
powerful tools to specifically block P2XR signaling in vivo. In the present study, we investigated the
behavioral phenotypes of a line of mice in which the p2rx4 gene was disrupted in a series of acute
and chronic pain assays. While p2rx4-/- mice showed no major defects in pain responses evoked by
acute noxious stimuli and local tissue damage or in motor function as compared with wild-type
mice, these mice displayed reduced pain responses in two models of chronic pain (inflammatory
and neuropathic pain). In a model of chronic inflammatory pain developed by intraplantar injection
of complete Freund's adjuvant (CFA), p2rx4-/- mice exhibited attenuations of pain hypersensitivity
to innocuous mechanical stimuli (tactile allodynia) and also of the CFA-induced swelling of the
hindpaw. A most striking phenotype was observed in a test of neuropathic pain: tactile allodynia
caused by an injury to spinal nerve was markedly blunted in p2rx4-/- mice. By contrast, pain
hypersensitivity to a cold stimulus (cold allodynia) after the injury was comparable in wild-type and
p2rx4-/- mice. Together, these findings reveal a predominant contribution of P2X4R to nerve injury-
induced tactile allodynia and, to the lesser extent, peripheral inflammation. Loss of P2X4R produced
no defects in acute physiological pain or tissue damaged-induced pain, highlighting the possibility of
a therapeutic benefit of blocking P2X4R in the treatment of chronic pain, especially tactile allodynia
after nerve injury.
Findings
The purinergic P2X receptors, of which seven subtypes
(P2X1–P2X7) have been cloned, are a family of ligand-
gated cation channels activated by extracellular ATP. They
have important roles in regulating neuronal and glial
functions in the nervous system under physiological and
pathological conditions [1-3]. There has been much
recent attention paid to their roles in generating and mod-
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ulating pain signaling [1-3]. Various attempts to block
P2XRs pharmacologically or to suppress their expression
molecularly and genetically have demonstrated that these
receptors make a major contribution to pain responses
evoked by tissue damage, chronic peripheral inflamma-
tion and nerve injury [4-6]. While the role of P2X3R (and
P2X2+3R) has been studied extensively, recent evidence
from our and other studies indicates that the P2X4R sub-
type critically contributes to neuropathic pain, a highly
debilitating pain condition that commonly occurs after
nerve damage [7-13]. However, the precise role of P2X4R
in neuropathic pain remains to be fully determined
because, in stark contrast to P2X3R [14-16] and P2X7R
[17,18], there is a lack of sufficiently powerful pharmaco-
logical and genetic tools to selectively block P2X4R signal-
ing in vivo. Recently, several groups have independently
developed lines of mice in which the p2rx4 gene is dis-
rupted [19-21]. It is of particular importance to study the
phenotypes of these mice to determine the in vivo func-
tions of P2X4R in pain signaling [22]. In the present study,
we sought to characterize behavioral phenotypes in a wide
range of assays of acute and chronic pain, including neu-
ropathic pain, using a line of P2X4R-deficient mice [19].
To examine acute physiological pain responses, the with-
drawal responses from a noxious range of heat and
mechanical stimuli applied by von Frey filaments were
measured in both wild-type and p2rx4-/- mice. In tail- and
paw-flick tests, the latencies for animals to flick their tails
and hindpaws away from radiant heat at either 30 V or 50
V were not different between wild-type and p2rx4-/- mice
(Fig. 1A, B). In a test of mechanical pain, p2rx4-/- mice
were indistinguishable from wild-type mice in terms of
their paw withdrawal thresholds (Fig. 1C). Abdominal
writhing behavior in response to intraperitoneal injection
with acetic acid, a model of chemical-induced visceral
pain, was also comparable between the two lines of mice
(Fig. 1D). To determine the role of P2X4R in tissue injury-
induced acute and persistent pain, we assessed the pain
response following the injection of formalin into the
hindpaw. In wild-type mice, injection of formalin elicited
biphasic biting and licking behaviors: the first phase
started immediately after the injection and lasted for 5
min, and the second phase lasted for 60 min (Fig. 1E).
Neither the pattern nor the magnitude of biphasic behav-
iors was altered in p2rx4-/- mice (Fig. 1E). The amount of
swelling of the formalin-injected hindpaw, as indicated by
an increase in the weight of the hindpaw 60 min after the
injection, was not significantly different between the two
lines of mice (contralateral hindpaw: wild-type 0.137 ±
0.008 g, p2rx4-/- 0.130 ± 0.004 g; ipsilateral: wild-type
0.173 ± 0.005 g, p2rx4-/- 0.181 ± 0.005 g). These results
indicate that pain signaling elicited by acute noxious stim-
uli and tissue damage is intact in p2rx4-/- mice.
Next, to investigate the role of P2X4R in pain hypersensi-
tivity under chronic pain conditions, we employed two
distinct models of chronic pain, namely inflammatory
and neuropathic pain. Wild-type mice with peripheral
inflammation induced by intraplantar injection of com-
plete Freund's adjuvant (CFA), used as a model of inflam-
matory pain, displayed decreased paw withdrawal
thresholds in their ipsilateral hindpaws (Fig. 2A). By con-
trast, the peripheral inflammation-induced decrease in
paw withdrawal threshold was significantly smaller in
p2rx4-/- mice than wild-type mice. The paw withdrawal
thresholds for the contralateral hindpaws in both geno-
types of mice did not change (Fig. 2A). In wild-type mice,
a marked swelling of the ipsilateral hindpaw was
observed, and the weight of the hindpaw was increased on
day 14 (Fig. 2B). In p2rx4-/- mice, however, the CFA-
induced increase in the weight of the ipsilateral hindpaw
was significantly suppressed (p < 0.05, Fig. 2B).
To determine the role of P2X4R in tactile allodynia under
neuropathic pain conditions, we injured the forth lumbar
spinal nerves of wild-type and p2rx4-/- mice; this approach
has been used to generate an animal model of neuro-
pathic pain. While wild-type mice showed a decrease in
paw withdrawal threshold after nerve injury (Fig. 3A), this
effect was markedly blunted in p2rx4-/- mice. The attenu-
ated tactile allodynia was observed until the last time
point tested (day 1, p < 0.05; day 3, 7, 10 and 14, p <
0.001; Fig. 3A). The loss of P2X4R did not change the paw
withdrawal threshold of the contralateral hindpaw after
nerve injury (Fig. 3A) as seen in wild-type mice (except on
day 1, p < 0.05 vs. wild-type, Fig. 3A). A reduction in pain
behaviors is occasionally misinterpreted as a result of
non-specific motor dysfunction, but the rotarod perform-
ance test demonstrated no significant difference in the
time on the rotarod between the two genotypes (data not
shown). We further tested whether P2X4R deficiency also
suppresses nerve injury-induced hypersensitivity to cold
stimulation, a phenomenon known as cold allodynia. In
striking contrast to the lack of nerve injury-induced tactile
allodynia in p2rx4-/- mice (Fig. 3A), both wild-type and
p2rx4-/- mice showed markedly enhanced responsiveness
to a cold stimulus evoked by applying acetone to the ipsi-
lateral hindpaw after nerve injury (Fig. 3B). There was no
difference in the behavioral response to acetone in the
contralateral hindpaw between the two lines of mice
(wild-type, 3.2 ± 0.3; p2rx4-/-, 3.2 ± 0.4). These results
indicate that P2X4R deficiency leads to a striking reduc-
tion in the tactile allodynia caused by nerve injury and, to
the lesser extent, peripheral inflammation, without any
defects in motor function.
By using P2X4R-deficient mice, we revealed that P2X4R is
not required for all forms of pain responses, but rather is
crucial for specialized pain states, namely chronic inflam-Molecular Pain 2009, 5:28 http://www.molecularpain.com/content/5/1/28
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Acute thermal and mechanical pain and chemical-induced pain in p2rx4-/- mice Figure 1
Acute thermal and mechanical pain and chemical-induced pain in p2rx4-/- mice. (A) Tail-flick and (B) paw-flick tests. 
Values represent the latency (sec) for animals to flick their tail or paw away from the heat source (wild-type, n = 5; p2rx4-/-, n 
= 4). (C) Mechanical pain test. Values indicate the threshold (g) to elicit paw withdrawal behavior in response to mechanical 
stimuli (wild-type, n = 5; p2rx4-/-, n = 4). (D) Visceral pain in response to acetic acid (0.8%). Values represent the numbers of 
abdominal stretches (writhes) (wild-type, n = 6; p2rx4-/-, n = 5). (E) Formalin test. Mice were injected intraplantarly with forma-
lin (5%, 20 μL). Values represent the duration (sec) of licking and biting responses for each 5-min interval (E), from 0 to 5 min 
(1st phase) and for 10–60 min (2nd phase) (inset) (wild-type, n = 8; p2rx4-/-, n = 6). All data are presented as means ± SEM.Molecular Pain 2009, 5:28 http://www.molecularpain.com/content/5/1/28
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matory and, in particular, neuropathic pain. Our present
results showing the striking reduction of tactile allodynia
after an injury to spinal nerves in p2rx4-/- mice together
with our previous findings in rats [7] and recent findings
in a line of p2rx4-/- mice after an injury to the sciatic nerve
[22] provide compelling evidence for an essential role of
P2X4R in nerve injury-induced tactile allodynia. To eluci-
date the mechanisms underlying the blunted neuropathic
allodynia in p2rx4-/- mice requires further investigations,
but it may involve a lack of microglial P2X4Rs in the spinal
cord, expression of which is markedly upregulated after
nerve injury [7,22]. Stimulation of P2X4R in microglia
induces release of brain-derived neurotrophic factor
[9,22,23], a factor that is crucial for producing aberrant
excitability of dorsal horn neurons [9,24]. Therefore, the
attenuated neuropathic allodynia in p2rx4-/- mice may be
associated with a reduction in the amount of pathologi-
cally altered neurotransmission in dorsal horn neurons
caused by microglia-derived BDNF [22].
An interesting finding in the present study was that nerve
injury-induced cold allodynia was retained in p2rx4-/-
mice, indicating that P2X4R may have distinct roles in
mechanical and cold hypersensitivities after nerve injury.
In a recent study it was shown that inhibition of Src-fam-
ily kinases (SFKs), whose activity is enhanced in spinal
microglia after nerve injury, results in suppression of tac-
tile allodynia without affecting cold allodynia [25]. Our
previous study has implicated Lyn (microglial SFK) as a
critical kinase causing P2X4R upregulation [13]. It is thus
conceivable that P2X4R-dependent microglial signaling in
the dorsal horn may participate predominantly in allody-
nia evoked by mechanical rather than cold stimulation
after peripheral nerve injury.
Our present study showed a reduction in the level of CFA-
induced inflammatory pain in p2rx4-/- mice. In contrast to
the neuropathic pain model, neither the upregulation of
P2X4R expression [7] nor activation of Lyn tyrosine kinase
[13] has been demonstrated in spinal microglia following
peripheral inflammation caused by CFA. The mechanisms
underlying the reduction in the amount of inflammatory
pain remain unknown, but the phenotype may be related
to a reduction in hindpaw inflammation in p2rx4-/- mice.
This notion is supported by evidence of expression of
functional P2X4Rs in peripheral inflammatory cells,
including macrophages [21,26].
In conclusion, by employing a series of acute and chronic
pain tests using mice lacking P2X4R, we demonstrated
that the loss of P2X4R leads to a marked reduction in the
degree of tactile allodynia caused by nerve injury and, to a
lesser extent, in peripheral inflammation, without any
defects in motor function. By contrasting the roles of
Reduction in the amount of peripheral inflammation-induced pain in p2rx4-/- mice Figure 2
Reduction in the amount of peripheral inflammation-induced pain in p2rx4-/- mice. (A) Paw withdrawal thresholds 
(left panel, ipsilateral hindpaw; right panel, contralateral hindpaw) of wild-type (n = 8) and p2rx4-/- mice (n = 8) before (0) and 1, 
3, 7, 10 and 14 days after intraplantar injection of CFA (0.01 mg/20 μL). *p < 0.05, **p < 0.01, ***p < 0.001 vs. wild-type mice. 
(B) Change in the weight (g) of the ipsilateral and contralateral hindpa0w 14 days after the injection of CFA (wild-type, n = 6; 
p2rx4-/-, n = 6). *p < 0.05 vs. wild-type mice. All data are presented as means ± SEM.Molecular Pain 2009, 5:28 http://www.molecularpain.com/content/5/1/28
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P2X4R in distinct types of nerve injury-induced pain
hypersensitivities, namely tactile and cold allodynia, the
present study demonstrates a predominant contribution
of P2X4R to tactile allodynia rather than cold allodynia.
The fact that acute physiological pain and tissue damage-
induced pain were normal in p2rx4-/- mice highlights the
possibility of a therapeutic benefit of blocking P2X4R in




All experimental procedures were performed under the
guidelines of Kyushu University. Male mice lacking P2X4R
(p2rx4-/-) that were backcrossed to C57BL/6J (Clea Japan)
for more than 10 generations were kindly provided by
Prof. Joji Ando (The University of Tokyo) [19], and we
used C57BL/6J as the corresponding control mice. All
mice were used at age of 9~11-week-old (at the start of
each experiment). Mice were housed in groups of 2~3 per
cage at a temperature of 22 ± 1°C with a 12-h light-dark
cycle (light on 8:30 to 20:30), and fed food and water ad
libitum.
Behavioral assays for acute and chronic pain
Noxious heat-evoked tail and hindpaw withdrawal
responses were detected by the application of radiant heat
(Ugo Basile, Italy) to the tail and the plantar surface of
hindpaw, respectively [27,28]. The intensity of the heat
stimulus was adjusted to 30 or 50 V, and the latency of the
paw withdrawal response (sec) was measured. The sensi-
tivity to mechanical stimulus was assessed using von Frey
filaments (0.02~2.0 g, Stoelting, Wood Dale, Illinois,
USA), and the mechanical stimulus producing the 50%
paw withdrawal threshold was determined using the up-
down method [29,30]. In the tests of formalin-induced
pain, mice were injected intraplantarly with formalin
(5%, 20 μL), and then the duration of the licking and bit-
ing responses to the injected hindpaw was recorded at 5
min intervals for 60 min after the injection (formalin
pain) [31,32]. For the measurement of hindpaw swelling
by formalin, the weights of the hind feet amputated at the
ankle were measured 60 min and 14 days after the injec-
tion of formalin and CFA, respectively [32]. In the chemi-
cal visceral pain test, mice were injected intraperitoneally
with acetic acid (0.8%), and the number of abdominal
writhes was counted for 5 min starting from 5 min after
the injection [32]. Motor coordination was assessed using
the rotarod performance test [31]. For the inflammatory
pain model, CFA (0.01 mg/20 μL) was injected into the
plantar surface of the left hindpaw [13]. For the neuro-
pathic pain model, the left L4 spinal nerve of mice was
transected under isoflurane (2%) anesthesia [33-35]. To
assess the tactile allodynia, mice were placed individually
Nerve injury-induced tactile allodynia is markedly blunted in p2rx4-/- mice Figure 3
Nerve injury-induced tactile allodynia is markedly blunted in p2rx4-/- mice. Paw withdrawal thresholds (left panel, 
ipsilateral hindpaw; right panel, contralateral hindpaw) of wild-type (n = 5) and p2rx4-/- mice (n = 6) before (0) and 1, 3, 7, 10 
and 14 days after spinal nerve injury. (B) Cold allodynia evoked by applying acetone to the plantar surface of the ipsilateral 
hindpaw 7 days after nerve injury (wild-type, n = 5; p2rx4-/-, n = 5). *p < 0.05, ***p < 0.001 vs. wild-type mice. All data are pre-
sented as means ± SEM.Molecular Pain 2009, 5:28 http://www.molecularpain.com/content/5/1/28
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in an opaque plastic cylinder which was placed on a wire
mesh and habituated for 1 hr to allow acclimatization to
the new environment. After that, calibrated von Frey fila-
ments (0.02–2.0 g, Stoelting) were applied to the plantar
surface of the hindpaw from below the mesh floor, and
the 50% paw withdrawal threshold was determined. To
assess cold allodynia [36], a drop (50 μL) of acetone was
placed against the centre of the plantar surface of the
hindpaw and a stopwatch was started. The mouse's
response was monitored in the first 20 sec after acetone
application. If the mouse did not withdraw, flick or stamp
its hindpaw within this 20-sec period then no response
was recorded for that trial (0). However, if within this 20
sec period the animal responded to the cooling effect of
the acetone, then the animal's response was assessed for
an additional 20 sec (a total of 40 sec from initial applica-
tion). Responses to acetone were graded according to the
following four-point scale: 0, no response; 1, quick with-
drawal, flick or stamp of the paw; 2, prolonged with-
drawal or repeated flicking (more than 2 times) of the
paw; 3, repeated flicking of the paw with licking directed
at the plantar surface of the hindpaw. Acetone was applied
alternately five times to each hindpaw and the responses
were scored categorically. Cumulative scores were then
generated for each mouse.
Statistical Analysis
The statistical analyses of the results were evaluated by
using the Student’s t test or the Mann-Whitney U test.
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